Company / Cost of Revenue
Xtant Medical Holdings, Inc. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$49.1M
FY2025
5-year range
$18.9M / $49.1M
FY2021-FY2025
Trend
+36.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has increased for 4 consecutive years, from $19M in FY2021 to $49M in FY2025.
Based on SEC 10-K filings.
$49M in FY2025 with a 5-year CAGR of +17.2%.
Increased from $26M to $49M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +29.1%
- 5-Year CAGR
- +17.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- Xtant Medical Holdings, Inc.'s cost of revenue has grown for 4 consecutive years.
- 5-year CAGR of +17.2%, indicating consistent growth.
- In FY2025, cost of revenue increased 36.9% year-over-year.
- Lowest cost of revenue in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $49.1M | +36.9% |
| FY2024 | $35.8M | +38.7% |
| FY2023 | $25.8M | +13.4% |
| FY2022 | $22.8M | +20.2% |
| FY2021 | $18.9M | -14.5% |
| FY2020 | $22.2M | -22.8% |
| FY2019 | $28.7M | -11.7% |
| FY2018 | $32.5M | +17.3% |
| FY2017 | $27.7M | +36.8% |
| FY2016 | $20.3M | +55.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026